Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
ICHR reports after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers and guidance.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-08-03 | +$4.96 (+6.59%) | $11.02 (14.63%) | -$8.96 (-11.17%) | $7.78 (9.70%) |
| 2026-05-04 | +$5.30 (+8.23%) | $5.01 (7.78%) | -$1.95 (-2.80%) | $11.20 (16.06%) |
| 2026-02-09 | +$1.96 (+6.10%) | $2.91 (9.07%) | +$11.16 (+32.72%) | $7.07 (20.72%) |
| 2025-11-03 | +$0.24 (+1.06%) | $1.18 (5.20%) | -$7.20 (-31.39%) | $2.11 (9.21%) |
| 2025-08-04 | +$0.76 (+3.92%) | $0.91 (4.70%) | -$6.08 (-30.19%) | $1.61 (7.99%) |
| 2025-05-05 | -$0.15 (-0.71%) | $0.72 (3.43%) | -$4.84 (-23.22%) | $1.59 (7.63%) |
| 2025-02-04 | +$1.19 (+4.40%) | $1.30 (4.81%) | +$4.06 (+14.41%) | $2.43 (8.60%) |
| 2024-11-04 | -$0.21 (-0.77%) | $0.70 (2.56%) | +$4.36 (+16.06%) | $1.80 (6.63%) |
| Avg Abs Move | 3.97% | 6.52% | 20.25% | 10.82% |
Historical price behavior around earnings shows extreme volatility, particularly on Day +1 when the market digests results. Over the past eight quarters, the stock has averaged an absolute Day 0 move of 3.97% with an intraday range of 6.52%—relatively modest anticipatory swings. However, Day +1 moves have been dramatic, averaging 20.25% in absolute terms with a 10.82% intraday range.
The most recent earnings (Q2 2026 on August 3) illustrates this pattern: the stock jumped 6.59% on Day 0, then reversed sharply with an -11.17% decline on Day +1 despite beating estimates. This suggests the market was disappointed by guidance or forward commentary even as the quarter itself exceeded expectations. The prior quarter (Q1 2026) saw an 8.23% Day 0 gain followed by a more modest -2.80% Day +1 decline.
Looking further back, the February 2026 report (Q4 2025 results) produced a massive +32.72% Day +1 surge, likely reflecting relief that losses were narrowing faster than expected. Conversely, the November 2025 report saw a brutal -31.39% Day +1 collapse, and August 2025 dropped -30.19%—both reflecting the depth of the downcycle.
The takeaway: ICHR exhibits outsized post-earnings moves, with Day +1 reactions frequently exceeding 20% as the market reassesses the cyclical trajectory. Recent quarters show some moderation from the extreme swings of 2025, but volatility remains elevated. Investors should expect significant price action regardless of whether the company beats or misses estimates, with guidance and forward commentary often mattering more than the quarter itself.
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 21) |
| Expected Move | $7.06 (18.14%) |
| Expected Range | $31.85 to $45.96 |
| Implied Volatility | 111.89% |
The options market is pricing an 18.14% expected move through the November 20 expiration (21 days out), implying a range of $31.85 to $45.96. This is slightly below the 20.25% average absolute Day +1 move observed historically, but well above the 3.97% average Day 0 move. Given that ICHR reports after the close, the options market appears to be pricing in a substantial post-earnings reaction that aligns with—but is slightly more conservative than—the stock's historical volatility. The 111.89% average implied volatility reflects elevated uncertainty heading into the release.
Analysts maintain a bullish stance on ICHR despite recent price weakness, with a consensus rating of 4.44 out of 5.00 (between Buy and Strong Buy). The breakdown shows 6 Strong Buys, 1 Moderate Buy, and 2 Holds—no sell ratings. However, sentiment has deteriorated over the past month, with the average recommendation slipping from 4.57 as one analyst downgraded from Strong Buy to Hold.
The average price target sits at $88.78, implying +128% upside from the current $38.90 price. Targets range from a low of $66.00 to a high of $115.00, reflecting divergent views on how quickly the margin recovery can translate into sustained profitability. The wide target range—spanning nearly $50—underscores uncertainty about the pace and durability of the semiconductor equipment upcycle.
The recent sentiment deterioration appears tied to the stock's sharp pullback rather than fundamental concerns, as most analysts continue to emphasize the margin improvement story and AI-driven demand tailwinds. The consensus view holds that current valuation (EV/Sales around 1.43x according to recent commentary) has become reasonable if margins can sustain at the 14.5-15.5% level management is targeting. However, the negative Earnings ESP suggests some analysts have trimmed near-term estimates, likely reflecting caution about the pace of recovery or potential for conservative Q4 guidance.
The Barchart Technical Opinion has deteriorated sharply, currently showing an 88% Sell signal—unchanged from last week but a dramatic shift from the 32% Sell reading just one month ago. This reflects the stock's steep decline from recent highs, with ICHR now trading at $38.90, well below all major moving averages.
Timeframe Analysis:
Trend Characteristics: The signal strength is rated as "Good" with "Strongest" direction, indicating high confidence in the current bearish trend heading into earnings.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $40.64 | 50-Day MA | $53.07 |
| 10-Day MA | $40.85 | 100-Day MA | $68.36 |
| 20-Day MA | $47.82 | 200-Day MA | $60.87 |
The technical setup is decidedly cautionary. ICHR trades below all key moving averages: the 5-day ($40.64), 10-day ($40.85), 20-day ($47.82), 50-day ($53.07), 100-day ($68.36), and 200-day ($60.87). The stock has broken down through multiple support levels, with the nearest resistance now at the 5-day and 10-day averages around $40.65-$40.85. The 20-day average at $47.82 represents a more significant overhead hurdle.
The uniformly bearish technical picture suggests the stock is oversold heading into earnings, which could set up a relief rally if results and guidance exceed expectations. However, the breakdown below all moving averages also means ICHR lacks technical support—any disappointment could accelerate selling. The extreme Day +1 volatility historically observed (averaging over 20%) combined with the current oversold condition creates a high-risk, high-reward setup where the earnings reaction could be amplified in either direction.